Loading company details...
Beta
Latest Form 4 (Oct 19, 2026): Elizabeth Bhatt (President and COO): Exercise/Conversion of 4,000 shares, $27.2K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Insider | Transaction | Shares | Value |
|---|---|---|---|---|
| Oct 19, 2026 | Elizabeth Bhatt, President and COO | Exercise/Conversion | 4,000 | $27.2K |
| Sep 10, 2026 | Rajiv Patni, Chief Medical Officer | Grant/Award | 275,000 | n/a |
| Sep 3, 2026 | Daniel D. Long, SVP, Drug Discovery | Exercise/Conversion | 3,333 | $9.2K |
| Aug 14, 2026 | Third Rock Ventures V, L.P. | Sale | 147,059 | $7.39M |
| Aug 14, 2026 | RA CAPITAL MANAGEMENT, L.P. | Sale | 746,500 | $31.73M |
| Aug 13, 2026 | Elizabeth Bhatt, President and COO | Exercise/Conversion | 18,681 | $127.2K |
| Aug 5, 2026 | Daniel D. Long, SVP, Drug Discovery | Exercise/Conversion | 1,816 | $5.0K |
| Jul 17, 2026 | Elizabeth Bhatt, President and COO | Exercise/Conversion | 4,000 | $27.2K |
| Jul 2, 2026 | Daniel D. Long, SVP, Drug Discovery | Exercise/Conversion | 3,333 | $9.2K |
| Jun 30, 2026 | RA CAPITAL MANAGEMENT, L.P. | Grant/Award | 15,000 | n/a |